Physician profile
Niranjan Seshadri
NPI 1306840210
$3,122.61
in general payments reported to CMS, 2019-2025
16 companies · $1,067 in 2025
The $1,067 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $36.64 · 2021: $1,314 · 2022: $75.24 · 2023: $56.41 · 2024: $449 · 2025: $1,067.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,572.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,340.50 | 2021-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Endologix LLC | $1,219.82 | 2024-2025 | Alto Abdominal Stent Graft System, Torus Stent Graft System, Endocross Device |
| Novartis Pharmaceuticals Corporation | $115.30 | 2024 | |
| Boston Scientific Corporation | $112.63 | 2019-2025 | Cds - Mct/Cem Monitoring |
| E.R. Squibb & Sons, L.L.C. | $59.45 | 2022-2024 | Camzyos |
| Medtronic Vascular, INC. | $39.99 | 2019 | |
| Pfizer INC. | $31.11 | 2022 | |
| Stryker Corporation | $29.65 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $29.14 | 2021-2025 | In.Pact Admiral |
| Astrazeneca Pharmaceuticals LP | $26.13 | 2019 | |
| Cardiovascular Systems INC. | $25.54 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $23.50 | 2023 | Optimizer |
| Abiomed | $19.59 | 2024 | Impella |
| Inari Medical, INC. | $18.93 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kyowa Kirin, INC. | $16.77 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $14.56 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niranjan Seshadri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.